Amendments No. 2 and No. 3 to Employment Agreement Between Cardiogenesis Corporation and Michael J. Quinn

Contract Categories: Human Resources › Employment Agreements
Summary

Cardiogenesis Corporation and Michael J. Quinn have amended their original employment agreement to increase Mr. Quinn's annual salary. Amendment No. 2 raises his salary to $388,427 effective January 1, 2003, and Amendment No. 3 further increases it to $436,650 effective January 1, 2005. All other terms of the original agreement remain unchanged. These amendments are signed by both parties and specify only the salary adjustments.

Read More Arrow
EX-10.11 3 a07285exv10w11.htm EXHIBIT 10.11 exv10w11  

Exhibit 10.11

Amendment No. 2 to Employment Agreement
Dated September 27, 2001
Between Cardiogenesis Corporation as Company and
Michael J. Quinn as Executive

The terms and conditions of the Employment Agreement are hereby modified and amended as follows. Unless specifically defined in this Agreement, capitalized terms used herein shall have the meanings ascribed to them in the Employment Agreement.

Section 3.1, line 2, after “Three Hundred Thirty Thousand Dollars ($330,000) per annum” insert “and effective January 1, 2003, such salary shall be increased to an amount equal to Three Hundred Eighty Eight Dollars Four Hundred Twenty Seven ($388,427) per annum”.

All other terms and conditions of the Employment Agreement shall remain the same.

IN WITNESS THEREOF, the parties hereto have executed this Amendment of the latest date set forth below.

                 
COMPANY:       EXECUTIVE:
CARDIOGENESIS CORPORATION       MICHAEL J. QUINN
 
                
BY:
  Darrell Eckstein       BY:   Michael Quinn
               
 
                
NAME:
  Darrell Eckstein       NAME:   Michael Quinn
               
 
                
TITLE:
  President, CFO       TITLE:   CEO & Chairman
               
 
                
DATE:
  5/19/03       DATE:   5/19/03
               

 

 

Amendment No. 3 to Employment Agreement
Dated September 27, 2001
Between Cardiogenesis Corporation as Company and
Michael J. Quinn as Executive

The terms and conditions of the Employment Agreement are hereby modified and amended as follows. Unless specifically defined in this Agreement, capitalized terms used herein shall have the meanings ascribed to them in the Employment Agreement.

Section 3.1, line 2, after “Three Hundred Thirty Thousand Dollars ($330,000) per annum” insert “and effective January 1, 2005, such salary shall be increased to an amount equal to Four Hundred Thirty-Six Thousand Six Hundred Fifty Dollars ($436,650) per annum”.

All other terms and conditions of the Employment Agreement shall remain the same.

IN WITNESS THEREOF, the parties hereto have executed this Amendment of the latest date set forth below.

                 
COMPANY:       EXECUTIVE:
CARDIOGENESIS CORPORATION       MICHAEL J. QUINN
 
                
BY:
  Christine Ocampo       BY:   Michael J. Quinn
               
 
                
NAME:
  Christine Ocampo       NAME:   Michael J. Quinn
               
 
                
TITLE:
  VP, Chief Financial Officer       TITLE:   President and CEO
               
 
                
DATE:
  3/16/05       DATE:   3/16/05